Micro Developing Active

Analyse du dividende de Bristol Myers Squibb

Gaining traction — growing article coverage and momentum.

Score
0,4
Vélocité
▲ 1,0
Articles
8
Sources
2

Sentiment Timeline

Event Timeline

Avr 13, 2026
Which Dividend Pharma Stock Should a Value Investor Choose Today? Neutral
Mar 31, 2026
Ariel Global Fund Re-Added Bristol-Myers Squibb Company (BMY) on Pipeline Strength and … Bullish
Mar 30, 2026
Bristol Gate Capital Partners Sold Zoetis (ZTS) Due to Deteriorating Dividend Growth Bearish
Mar 28, 2026
Bristol-Myers Squibb (BMY) Faces Mixed Analyst Sentiment Despite Strong Momentum in Healthcare … Neutral
Mar 23, 2026
Should You Buy Bristol Myers Squibb Stock for Its 4.4%-Yielding Dividend? Neutral

Articles Liés

Is Bristol-Myers Squibb Company (BMY) A Good Stock To Buy Now?

Yahoo Finance · Mar 30, 2026
Bearish

Should You Buy Bristol Myers Squibb Stock for Its 4.4%-Yielding Dividend?

Nasdaq · Mar 23, 2026
Mixed

Chronologie

Première observationMar 23, 2026
Dernière mise à jourMar 23, 2026